We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Achillion Pharmaceuticals Inc | NASDAQ:ACHN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.76 | 6.93 | 6.75 | 0 | 01:00:00 |
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person
*
RA CAPITAL MANAGEMENT, LLC |
2. Issuer Name
and
Ticker or Trading Symbol
ACHILLION PHARMACEUTICALS INC [ ACHN ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner _____ Officer (give title below) __ X __ Other (specify below) Former 10% Owner. See FN(1)(6) |
C/O RA CAPITAL MANAGEMENT, LLC, 20 PARK PLAZA, SUITE 1200 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
BOSTON, MA 02116 |
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person _ X _ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security
(Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock, $0.001 par value | 7/17/2013 | P | 38400 | A | $7.0934 | 5365873 | D (1) (6) | |||
Common Stock, $0.001 par value | 7/19/2013 | S | 38400 | D | $7.2125 | 5327473 | D (1) (6) | |||
Common Stock, $0.001 par value | 7/22/2013 | P | 24883 | A | $7.1600 | 5365873 | D (1) (6) | |||
Common Stock, $0.001 par value | 7/22/2013 | P | 38400 | A | $7.2311 | 5340990 | D (1) (6) | |||
Common Stock, $0.001 par value | 7/24/2013 | S | 7862 | D | $7.2552 | 5302590 | D (1) (6) | |||
Common Stock, $0.001 par value | 7/25/2013 | P | 37250 | A | $7.1947 | 5310452 | D (1) (6) | |||
Common Stock, $0.001 par value | 7/25/2013 | S | 14592 | D | $7.1500 | 5273202 | D (1) (6) | |||
Common Stock, $0.001 par value | 7/25/2013 | S | 40829 | D | $7.1948 | 5287794 | D (1) (6) | |||
Common Stock, $0.001 par value | 7/29/2013 | P | 11441 | A | $6.9000 | 5328623 | D (1) (6) | |||
Common Stock, $0.001 par value | 7/29/2013 | P | 6453 | A | $6.9050 | 5317182 | D (1) (6) | |||
Common Stock, $0.001 par value | 7/29/2013 | S | 3377 | D | $6.9525 | 5310729 | D (1) (6) | |||
Common Stock, $0.001 par value | 8/2/2013 | P | 23100 | A | $6.9835 | 5314106 | D (1) (6) | |||
Common Stock, $0.001 par value | 8/5/2013 | S | 23100 | D | $7.1141 | 5291006 | D (1) (6) | |||
Common Stock, $0.001 par value | 8/9/2013 | P | 77000 | A | $6.300 | 5314106 | D (1) (6) | |||
Common Stock, $0.001 par value | 8/20/2013 | P | 38500 | A | $6.7492 | 5237106 | D (1) (6) | |||
Common Stock, $0.001 par value | 8/20/2013 | S | 9951 | D | $6.8643 | 5198606 | D (1) (6) | |||
Common Stock, $0.001 par value | 8/21/2013 | P | 23100 | A | $6.6922 | 5208557 | D (1) (6) | |||
Common Stock, $0.001 par value | 8/21/2013 | S | 4312 | D | $6.8741 | 5185457 | D (1) (6) | |||
Common Stock, $0.001 par value | 8/22/2013 | P | 52652 | A | $6.7645 | 5189769 | D (1) (6) | |||
Common Stock, $0.001 par value | 8/26/2013 | P | 115500 | A | $6.5750 | 5137117 | D (1) (6) | |||
Common Stock, $0.001 par value | 8/26/2013 | P | 38500 | A | $6.5800 | 5021617 | D (1) (6) | |||
Common Stock, $0.001 par value | 8/27/2013 | P | 77000 | A | $6.4850 | 4983117 | D (1) (6) | |||
Common Stock, $0.001 par value | 8/28/2013 | P | 38500 | A | $6.3850 | 4906117 | D (1) (6) | |||
Common Stock, $0.001 par value | 9/11/2013 | P | 19400 | A | $7.1800 | 4867617 | D (1) (6) | |||
Common Stock, $0.001 par value | 9/11/2013 | P | 19400 | A | $7.2050 | 4848217 | D (1) (6) | |||
Common Stock, $0.001 par value | 9/11/2013 | S | 38800 | D | $7.300 | 4828817 | D (1) (6) | |||
Common Stock, $0.001 par value | 9/12/2013 | P | 6906 | A | $7.1950 | 4867617 | D (1) (6) | |||
Common Stock, $0.001 par value | 9/12/2013 | P | 4190 | A | $7.2050 | 4860711 | D (1) (6) | |||
Common Stock, $0.001 par value | 9/12/2013 | P | 7761 | A | $7.2050 | 4856521 | D (1) (6) | |||
Common Stock, $0.001 par value | 9/12/2013 | S | 18857 | D | $7.2650 | 4848760 | D (1) (6) |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Call Option (right to buy) | $7.50 | 7/15/2013 | P | 768 | (2) | 1/17/2015 | Common Stock | 76800 (3) | $2.6445 | 768 | D (1) (6) | ||||
Call Option (obligation to sell) | $20.00 | 7/15/2013 | S | 768 | (2) | 1/17/2015 | Common Stock | 76800 (3) | $0.3945 | 768 | D (1) (6) | ||||
Call Option (right to buy) | $7.50 | 7/25/2013 | P | 3072 | (2) | 1/17/2015 | Common Stock | 307200 (4) | $2.7500 | 3072 | D (1) (6) | ||||
Call Option (obligation to sell) | $20.00 | 7/25/2013 | S | 3072 | (2) | 1/17/2015 | Common Stock | 307200 (4) | $0.4000 | 3072 | D (1) (6) | ||||
Call Option (right to buy) | $7.50 | 9/26/2013 | P | 7760 | (2) | 1/18/2014 | Common Stock | 776000 (5) | $1.3649 | 7760 | D (1) (6) | ||||
Call Option (obligation to sell) | $15.00 | 9/26/2013 | S | 7760 | (2) | 1/18/2014 | Common Stock | 776000 (5) | $0.0472 | 7760 | D (1) (6) |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
RA CAPITAL MANAGEMENT, LLC
C/O RA CAPITAL MANAGEMENT, LLC 20 PARK PLAZA, SUITE 1200 BOSTON, MA 02116 |
|
|
|
Former 10% Owner. See FN(1)(6) | |
RA Capital Healthcare Fund LP
C/O RA CAPITAL MANAGEMENT, LLC 20 PARK PLAZA, SUITE 1200 BOSTON, MA 02116 |
|
X |
|
|
|
Kolchinsky Peter
C/O RA CAPITAL MANAGEMENT, LLC 20 PARK PLAZA, SUITE 1200 BOSTON, MA 02116 |
|
X |
|
|
Signatures
|
||
/s/ Peter Kolchinsky, Manager of RA Capital Management, LLC | 1/20/2015 | |
** Signature of Reporting Person |
Date
|
|
/s/ Peter Kolchinsky, individually | 1/20/2015 | |
** Signature of Reporting Person |
Date
|
|
/s/ Peter Kolchinsky, Manager of RA Capital Management, LLC, the General Partner of RA Capital Healthcare Fund, L.P. | 1/20/2015 | |
** Signature of Reporting Person |
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Achillion Pharmaceuticals Chart |
1 Month Achillion Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions